Your browser doesn't support javascript.
loading
Evaluation of extended release brimonidine intravitreal device in normotensive rabbit eyes.
Deokule, Sunil P; Baffi, Judit Z; Guo, Hong; Nazzaro, Marty; Kaneko, Hiroki.
Afiliação
  • Deokule SP; Department of Ophthalmology and Visual Sciences, University of Kentucky, Lexington, KY, USA. spdeokule@gmail.com
Acta Ophthalmol ; 90(5): e344-8, 2012 Aug.
Article em En | MEDLINE | ID: mdl-22676067
ABSTRACT

PURPOSE:

To evaluate the safety profile of a brimonidine extended release intravitreal implant, in normotensive rabbit eyes.

METHODS:

Devices were made from hollow poly-l-lactic acid (PLA) tubes and contained hundred micrograms of brimonidine pamoate. Device was injected intravitreally in one eye of 12 New Zealand pigmented rabbits, whereas other eye was injected with a sham implant in masked fashion. Ocular examination was conducted at baseline and months 1, 3 and 6 including dilated fundus examination and electro-retinogram (ERG). Four rabbits were sacrificed at each time-point for retinal histology. ERG data were compared between groups and time-points using anova.

RESULTS:

No complications were reported from either eye of any rabbits over a 6-month period. Photopic A wave was reduced in the control eye at 1 month compared with baseline (p < 0.01). There was no significant difference in other ERG parameters between the groups at different time-points. Gross retinal histology was normal at all time-points.

CONCLUSION:

Extended release intravitreal brimonidine device was found to be safe and in normotensive rabbit eyes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinoxalinas / Corpo Vítreo / Portadores de Fármacos / Anti-Hipertensivos Limite: Animals Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinoxalinas / Corpo Vítreo / Portadores de Fármacos / Anti-Hipertensivos Limite: Animals Idioma: En Ano de publicação: 2012 Tipo de documento: Article